C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
12/2002
12/17/2002	CA1341409C Cloning and expression of htlv-iii dna
12/12/2002	WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002	WO2002099084A2 Composite binding polypeptides
12/12/2002	WO2002098920A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002	WO2002098914A2 Mutants of igf binding proteins and methods of production of antagonists thereof
12/12/2002	WO2002098456A2 Antigens and vectors for vaccination
12/12/2002	WO2002098365A2 Conditioned cell culture media and uses thereof
12/12/2002	WO2002098360A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
12/12/2002	WO2002086058A9 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
12/12/2002	WO2002079232A3 Reducing the immunogenicity of fusion proteins
12/12/2002	WO2002070552A3 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
12/12/2002	WO2002030958A3 Casein peptide fragments with growth-influencing activity on cell cultures
12/12/2002	WO2001093983A9 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/12/2002	US20020188103 Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof
12/12/2002	US20020188102 Peptide for use as microbiocides
12/12/2002	US20020187466 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection
12/12/2002	US20020187135 Methods for inducing antigen-specific t cell tolerance
12/12/2002	CA2452865A1 Conditioned cell culture media and uses thereof
12/12/2002	CA2449290A1 Mutants of igf binding proteins and methods of production of antagonists thereof
12/12/2002	CA2448427A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002	CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof
12/11/2002	EP1264888A2 A modified fluorescent protein
12/11/2002	EP1263982A1 Phosphatidyl serine receptors and uses thereof
12/11/2002	EP1263970A1 Identification of a dual specificity phosphatase: dusp-10
12/11/2002	EP1263960A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
12/11/2002	EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
12/11/2002	EP1263957A2 Human lipid binding protein 1
12/11/2002	EP1263948A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2002	EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10
12/11/2002	EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer
12/11/2002	EP1263779A1 Self antigen vaccines for treating b cell lymphomas and other cancers
12/11/2002	EP1263768A2 Chimeric neuropeptide y receptors
12/11/2002	EP0888384B1 Fusion polypeptide for modifying interactions between proteins
12/11/2002	CN1384758A Mutant human CD80 and copositions for and methods of making and using the same
12/10/2002	US6492492 Wild type streptavidin carboxyl terminal amino acid and the amino terminal amino acid of the wild type streptavidin have been joined directly or via a linker, and wherein new carboxyl and amino termini have been created by cleavage
12/10/2002	US6492331 NL8 tie ligands homologues
12/10/2002	US6492160 Methods for producing members of specific binding pairs
12/10/2002	US6492140 Polynucleotides encoding cytokine designated LERK-5
12/10/2002	US6491920 Polypeptides and DNA encoding same
12/10/2002	US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells
12/10/2002	CA2196085C Mhc complexes and uses thereof
12/10/2002	CA1341407C Minactivin
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097110A2 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF
12/05/2002	WO2002097059A2 Chromosome-based platforms
12/05/2002	WO2002097050A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
12/05/2002	WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002	WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	WO2002097042A2 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
12/05/2002	WO2002097030A2 Peptides derived from neural thread proteins and their medical use
12/05/2002	WO2002096952A2 Conjugate of a transport protein and a protein for modulation of notch signalling
12/05/2002	WO2002096951A1 Molecules for disease detection and treatment
12/05/2002	WO2002096467A2 Pharmaceutical use for secreted bacterial effector proteins
12/05/2002	WO2002062957A9 Ter sites and ter binding proteins
12/05/2002	WO2002059150A3 Materials and methods relating to protein aggregation in neurodegenerative disease
12/05/2002	WO2002028902A3 Nectin polypeptides, polynucleotides, methods of making and use thereof
12/05/2002	WO2002016413A3 Cripto tumour polypeptide
12/05/2002	WO2002013862A3 Method and composition for altering a b cell mediated pathology
12/05/2002	WO2001088085A3 Novel bee venom polypeptides and methods of use thereof
12/05/2002	WO2001079448A3 Trp8, a transient receptor potential channel expressed in taste receptor cells
12/05/2002	WO2001021796A9 Gl50 molecules and uses therefor
12/05/2002	WO2001019408A9 Nucleic acids encoding polyepitope polypeptides
12/05/2002	US20020183247 Lipoparticle comprising a protein and methods of making and using the same
12/05/2002	US20020182676 Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexia
12/05/2002	US20020182221 Recombinant papillomavirus vaccine and method for production and treatment
12/05/2002	CA2665748A1 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
12/05/2002	CA2448963A1 Pharmaceutical use for secreted bacterial effector proteins
12/05/2002	CA2448362A1 B7 related protein-2 molecules and uses thereof
12/05/2002	CA2448348A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
12/05/2002	CA2448116A1 Molecules for disease detection and treatment
12/05/2002	CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	CA2448100A1 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
12/05/2002	CA2447916A1 Tumor endothelial marker 7.alpha. molecules and uses thereof
12/05/2002	CA2447879A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	CA2441937A1 Chromosome-based platforms
12/04/2002	EP1262555A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells
12/04/2002	EP1261723A2 Hybrid expression of neisserial proteins
12/04/2002	EP1261721A1 Human extracellular signal regulated kinases
12/04/2002	EP1261709A1 Human abc transporter expressed in liver, atil
12/04/2002	EP1261708A2 Compositions and methods for the therapy and diagnosis of prostate cancer
12/04/2002	EP1261645A1 Anti-viral conjugate comprising a factor allowing the translocation of a protein across a cell membrane and comprising a single-chain antibody fragment directed against a viral protein
12/04/2002	EP1261627A2 Antibodies against plasma cells
12/04/2002	EP1261369A2 Compositions and methods for tumor-targeted delivery of effector molecules
12/04/2002	EP1030867A4 Mammalian milk growth factor
12/04/2002	EP0625197B1 Dna encoding kappa-casein, process for obtaining the protein and use thereof
12/04/2002	CN1382697A Human testis development specific protein-28 gene coding protein
12/04/2002	CN1382696A Human testis development specific protein-25 gene coding protein
12/04/2002	CN1382695A Human testis development specific protein-22 gene coding protein
12/04/2002	CN1382694A Human testis development specific protein-17 gene coding protein
12/03/2002	US6489445 Polypeptides which specifically bind to at least one human bone morphogenic protein (bmp) selected from bmp-5 and bmp-6
12/03/2002	US6489441 Transcriptional co-repressor that interacts with nuclear hormone receptors
12/03/2002	US6489145 Method of DNA shuffling
12/03/2002	CA2254853C Compositions and methods for screening antimicrobials
12/03/2002	CA2060544C Recombinant antibodies specific for a growth factor receptor
12/03/2002	CA2050910C Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
11/2002
11/28/2002	WO2002095414A1 Methods for screening using interleukin soluble trimolecular complex
11/28/2002	WO2002095058A2 Emission ratiometric indicators of phosphorylation
11/28/2002	WO2002095043A1 Cellular signal-responsive gene transcriptional regulation system
11/28/2002	WO2002095036A2 A novel intein and uses thereof
11/28/2002	WO2002094881A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof

1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 295